Hi,
https://www.einnews.com/pr_news/5564526 ... ogy-trends
"SEATTLE, WASHINGTON, UNITED STATES, November 16, 2021 /EINPresswire.com/ -- The increasing research and development activities and funding by various organizations for the development of monovaccine are expected to drive the market growth over the forecast period. Currently, there is no licensed vaccine for Epstein-Barr Virus (EBV). However, various universities and organizations are focusing on developing novel vaccines against EBV and cater to the unmet needs."...
...."Several government organizations from different regions are focusing on the development of novel monovaccines (Epstein - Barr virus) and also focuses on gaining approval from regulatory authorities. For instance, in 2019, researchers from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) determined how various antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory...."
Monovaccine (Epstein - Barr virus) Market Overview 2021
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2306 Views
-
Last post by NHE
-
- 1 Replies
- 289 Views
-
Last post by Leonard
-
- 2 Replies
- 854 Views
-
Last post by DIM
-
- 0 Replies
- 1885 Views
-
Last post by Tif
-
- 0 Replies
- 1673 Views
-
Last post by Tif
-
- 0 Replies
- 1428 Views
-
Last post by Tif
-
- 1 Replies
- 1108 Views
-
Last post by 1eye
-
- 0 Replies
- 1271 Views
-
Last post by frodo
-
- 2 Replies
- 2064 Views
-
Last post by Scott1